ODAIA Lands $13.8M in Series A Funding Led by Flint Capital, in an Oversubscribed Round
Summary
ODAIA is the first SaaS company to combine multivariate data analysis, process mining and AI to offer predictive analytics to pharmaceutical and life sciences commercial teams. Many of the world’s largest pharmaceutical companies have leveraged MAPTUAL for actionable commercial insights including Janssen, Novo Nordisk, AstraZeneca, among others. Health care providers’ preferences are shifting permanently toward digital engagement and personalised support. Our mission is to help pharmaceutical companies in delivering life-changing treatments to patients in the most efficient way possible by integrating robust data with software solutions and AI”, says Philip Poulidis, co-founder & CEO of ODAIA MAPTUAL consolidates a pharma company’s internal and external data and applies advanced analytics and machine learning to deliver predictive insights in real time to sales and marketing teams, including best-in-class predictive targeting and sales forecasting, physician segmentation, omni-channel attribution and next-best-engagement, allowing them to deploy resources more efficiently and create personalised customer engagements. “We are excited to partner with ODAIA as they bring powerful yet intuitively usable analytics and machine learning to empower the commercial side of Pharmaceutical companies,” says Fates.